Results of comprehensive neutron and photon therapy of topical breast cancers

L. I. Musabaeva, Zh A. Zhogina, E. M. Slonimskaya, V. A. Lisin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The 5-year results of the combined modality treatment with the use of neutron-photon therapy for patients with T3-4N0-1M0 locally advanced breast cancer (LABC) are presented. Fifty-three patients with primary locally advanced T3-4N0-1M0 breast cancer received 1-2 courses of neo-adjuvant chemotherapy according to CMF schedule with the standard dosage (42 patients), high-dosage chemotherapy (11 patients) and preoperative radiation therapy with 6.3 MeV neutrons within 8-12 days. Conventional gamma-therapy (total dose of 40-45 Gy) was delivered to the areas of potential regional spread and adjuvant chemotherapy was administered according to CMF schedule for 1.5-2 years. Local recurrences occurred 8 times more rarely in patients of the main group, who received the combined modality treatment applying the preoperative neutron therapy than those in the control group. Five-year recurrence-free survival rates in patients with locally-advanced breast cancer were as follows: 96.3 ± 3.6% in the group with neutron therapy and 80 ± 6.8% in the control group. The overall 5-year survival rates were higher in the main group of patients than those in patients of the control group (66.8 ± 8.5 and 56.5 ± 11.4%, respectively).

Original languageEnglish
Pages (from-to)51-58
Number of pages8
JournalMeditsinskaya Radiologiya I Radiatsionnaya Bezopasnost'
Volume49
Issue number2
Publication statusPublished - 2004
Externally publishedYes

Fingerprint

Chemotherapy
Neutrons
Photons
Radiotherapy

Keywords

  • Locally advanced breast cancer
  • Neutron-photon therapy
  • Therapy results

ASJC Scopus subject areas

  • Nuclear Energy and Engineering

Cite this

Musabaeva, L. I., Zhogina, Z. A., Slonimskaya, E. M., & Lisin, V. A. (2004). Results of comprehensive neutron and photon therapy of topical breast cancers. Meditsinskaya Radiologiya I Radiatsionnaya Bezopasnost', 49(2), 51-58.

Results of comprehensive neutron and photon therapy of topical breast cancers. / Musabaeva, L. I.; Zhogina, Zh A.; Slonimskaya, E. M.; Lisin, V. A.

In: Meditsinskaya Radiologiya I Radiatsionnaya Bezopasnost', Vol. 49, No. 2, 2004, p. 51-58.

Research output: Contribution to journalArticle

Musabaeva, LI, Zhogina, ZA, Slonimskaya, EM & Lisin, VA 2004, 'Results of comprehensive neutron and photon therapy of topical breast cancers', Meditsinskaya Radiologiya I Radiatsionnaya Bezopasnost', vol. 49, no. 2, pp. 51-58.
Musabaeva, L. I. ; Zhogina, Zh A. ; Slonimskaya, E. M. ; Lisin, V. A. / Results of comprehensive neutron and photon therapy of topical breast cancers. In: Meditsinskaya Radiologiya I Radiatsionnaya Bezopasnost'. 2004 ; Vol. 49, No. 2. pp. 51-58.
@article{c209e30ba25c484e9dd0918e8b720a39,
title = "Results of comprehensive neutron and photon therapy of topical breast cancers",
abstract = "The 5-year results of the combined modality treatment with the use of neutron-photon therapy for patients with T3-4N0-1M0 locally advanced breast cancer (LABC) are presented. Fifty-three patients with primary locally advanced T3-4N0-1M0 breast cancer received 1-2 courses of neo-adjuvant chemotherapy according to CMF schedule with the standard dosage (42 patients), high-dosage chemotherapy (11 patients) and preoperative radiation therapy with 6.3 MeV neutrons within 8-12 days. Conventional gamma-therapy (total dose of 40-45 Gy) was delivered to the areas of potential regional spread and adjuvant chemotherapy was administered according to CMF schedule for 1.5-2 years. Local recurrences occurred 8 times more rarely in patients of the main group, who received the combined modality treatment applying the preoperative neutron therapy than those in the control group. Five-year recurrence-free survival rates in patients with locally-advanced breast cancer were as follows: 96.3 ± 3.6{\%} in the group with neutron therapy and 80 ± 6.8{\%} in the control group. The overall 5-year survival rates were higher in the main group of patients than those in patients of the control group (66.8 ± 8.5 and 56.5 ± 11.4{\%}, respectively).",
keywords = "Locally advanced breast cancer, Neutron-photon therapy, Therapy results",
author = "Musabaeva, {L. I.} and Zhogina, {Zh A.} and Slonimskaya, {E. M.} and Lisin, {V. A.}",
year = "2004",
language = "English",
volume = "49",
pages = "51--58",
journal = "Meditsinskaya Radiologiya I Radiatsionnaya Bezopasnost'",
issn = "0025-8334",
publisher = "Izdatel'sto Radekon",
number = "2",

}

TY - JOUR

T1 - Results of comprehensive neutron and photon therapy of topical breast cancers

AU - Musabaeva, L. I.

AU - Zhogina, Zh A.

AU - Slonimskaya, E. M.

AU - Lisin, V. A.

PY - 2004

Y1 - 2004

N2 - The 5-year results of the combined modality treatment with the use of neutron-photon therapy for patients with T3-4N0-1M0 locally advanced breast cancer (LABC) are presented. Fifty-three patients with primary locally advanced T3-4N0-1M0 breast cancer received 1-2 courses of neo-adjuvant chemotherapy according to CMF schedule with the standard dosage (42 patients), high-dosage chemotherapy (11 patients) and preoperative radiation therapy with 6.3 MeV neutrons within 8-12 days. Conventional gamma-therapy (total dose of 40-45 Gy) was delivered to the areas of potential regional spread and adjuvant chemotherapy was administered according to CMF schedule for 1.5-2 years. Local recurrences occurred 8 times more rarely in patients of the main group, who received the combined modality treatment applying the preoperative neutron therapy than those in the control group. Five-year recurrence-free survival rates in patients with locally-advanced breast cancer were as follows: 96.3 ± 3.6% in the group with neutron therapy and 80 ± 6.8% in the control group. The overall 5-year survival rates were higher in the main group of patients than those in patients of the control group (66.8 ± 8.5 and 56.5 ± 11.4%, respectively).

AB - The 5-year results of the combined modality treatment with the use of neutron-photon therapy for patients with T3-4N0-1M0 locally advanced breast cancer (LABC) are presented. Fifty-three patients with primary locally advanced T3-4N0-1M0 breast cancer received 1-2 courses of neo-adjuvant chemotherapy according to CMF schedule with the standard dosage (42 patients), high-dosage chemotherapy (11 patients) and preoperative radiation therapy with 6.3 MeV neutrons within 8-12 days. Conventional gamma-therapy (total dose of 40-45 Gy) was delivered to the areas of potential regional spread and adjuvant chemotherapy was administered according to CMF schedule for 1.5-2 years. Local recurrences occurred 8 times more rarely in patients of the main group, who received the combined modality treatment applying the preoperative neutron therapy than those in the control group. Five-year recurrence-free survival rates in patients with locally-advanced breast cancer were as follows: 96.3 ± 3.6% in the group with neutron therapy and 80 ± 6.8% in the control group. The overall 5-year survival rates were higher in the main group of patients than those in patients of the control group (66.8 ± 8.5 and 56.5 ± 11.4%, respectively).

KW - Locally advanced breast cancer

KW - Neutron-photon therapy

KW - Therapy results

UR - http://www.scopus.com/inward/record.url?scp=4344610859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344610859&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 51

EP - 58

JO - Meditsinskaya Radiologiya I Radiatsionnaya Bezopasnost'

JF - Meditsinskaya Radiologiya I Radiatsionnaya Bezopasnost'

SN - 0025-8334

IS - 2

ER -